|
1
|
Chen S, Yuan J, Yao S, Jin Y, Chen G, Tian
W, Xi J, Xu Z, Weng D and Chen J: Lipopolysaccharides may aggravate
apoptosis through accumulation of autophagosomes in alveolar
macrophages of human silicosis. Autophagy. 11:2346–2357. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Castranova V and Vallyathan V: Silicosis
and coal workers' pneumoconiosis. Environ Health Perspect.
108:675–684. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murtha LA, Morten M, Schuliga MJ,
Mabotuwana NS, Hardy SA, Waters DW, Burgess JK, Ngo DT, Sverdlov
AL, Knight DA, et al: The role of pathological aging in cardiac and
pulmonary fibrosis. Aging Dis. 10:419–428. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mei L, Chen Y, Wang Z, Wang J, Wan J, Yu
C, Liu X and Li W: Synergistic anti-tumour effects of tetrandrine
and chloroquine combination therapy in human cancer: A potential
antagonistic role for p21. Br J Pharmacol. 172:2232–2245. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kolahian S, Fernandez IE, Eickelberg O and
Hartl D: Immune mechanisms in pulmonary fibrosis. Am J Respir Cell
Mol Biol. 55:309–322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu T, Liu X and Li W: Tetrandrine, a
Chinese plant-derived alkaloid, is a potential candidate for cancer
chemotherapy. Oncotarget. 7:40800–40815. 2016.PubMed/NCBI
|
|
7
|
Wynn TA: Integrating mechanisms of
pulmonary fibrosis. J Exp Med. 208:1339–1350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Strieter RM and Mehrad B: New mechanisms
of pulmonary fibrosis. Chest. 136:1364–1370. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun W, Tang H, Gao L, Sun X, Liu J, Wang
W, Wu T and Lin H: Mechanisms of pulmonary fibrosis induced by core
fucosylation in pericytes. Int J Biochem Cell Biol. 88:44–54. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Warburton D, Shi W and Xu B: TGF-β-Smad3
signaling in emphysema and pulmonary fibrosis: An epigenetic
aberration of normal development? Am J Physiol Lung Cell Mol
Physiol. 304:L83–L85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aono Y, Ledford JG, Mukherjee S, Ogawa H,
Nishioka Y, Sone S, Beers MF, Noble PW and Wright JR: Surfactant
protein-D regulates effector cell function and fibrotic lung
remodeling in response to bleomycin injury. Am J Respir Crit Care
Med. 185:525–536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Doyle TJ, Pinto-Plata V, Morse D, Celli BR
and Rosas IO: The expanding role of biomarkers in the assessment of
smoking-related parenchymal lung diseases. Chest. 142:1027–1034.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morrison MI, Pither TL and Fisher AJ:
Pathophysiology and classification of primary graft dysfunction
after lung transplantation. J Thorac Dis. 9:4084–4097. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pei JS, Chou AK, Hsu PC, Tsai CW, Chang
WS, Wu MF, Wu MH, Hsia TC, Cheng SP and Bau DT: Contribution of
matrix metalloproteinase-7 genotypes to the risk of non-solid
tumor, childhood leukemia. Anticancer Res. 37:6679–6684.
2017.PubMed/NCBI
|
|
15
|
Martinez FJ, Chisholm A, Collard HR,
Flaherty KR, Myers J, Raghu G, Walsh SL, White ES and Richeldi L:
The diagnosis of idiopathic pulmonary fibrosis: Current and future
approaches. Lancet Respir Med. 5:61–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song JW, Do KH, Jang SJ, Colby TV, Han S
and Kim DS: Blood biomarkers MMP-7 and SP-A: predictors of outcome
in idiopathic pulmonary fibrosis. Chest. 143:1422–1429. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rosas IO, Goldberg HJ, Collard HR,
El-Chemaly S, Flaherty K, Hunninghake GM, Lasky JA, Lederer DJ,
Machado R, Martinez FJ, et al: A phase II clinical trial of
low-dose inhaled carbon monoxide in idiopathic pulmonary fibrosis.
Chest. 153:94–104. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Flaherty KR, Andrei AC, Murray S, Fraley
C, Colby TV, Travis WD, Lama V, Kazerooni EA, Gross BH, Toews GB,
et al: Idiopathic pulmonary fibrosis: Prognostic value of changes
in physiology and six-minute-walk test. Am J Respir Crit Care Med.
174:803–809. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miyamoto S, Nagaya N, Satoh T, Kyotani S,
Sakamaki F, Fujita M, Nakanishi N and Miyatake K: Clinical
correlates and prognostic significance of six-minute walk test in
patients with primary pulmonary hypertension. Comparison with
cardiopulmonary exercise testing. Am J Respir Crit Care Med.
161:487–492. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma J, Zhou Y, Li W, Xiao L, Yang M, Tan Q,
Xu Y and Chen W: Association between plasma HMGB-1 and silicosis: A
case-control study. Int J Mol Sci. 19:40432018. View Article : Google Scholar
|
|
21
|
Wang SX, Liu P, Wei MT, Chen L, Guo Y,
Wang RY, Tu ZG and Liang XC: Roles of serum clara cell protein 16
and surfactant protein-D in the early diagnosis and progression of
silicosis. J Occup Environ Med. 49:834–839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Racanelli AC, Kikkers SA, Choi AMK and
Cloonan SM: Autophagy and inflammation in chronic respiratory
disease. Autophagy. 14:221–232. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong J and Ma Q: Macrophage polarization
and activation at the interface of multi-walled carbon
nanotube-induced pulmonary inflammation and fibrosis.
Nanotoxicology. 12:153–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Raha S, Kim SM, Lee HJ, Lee SJ, Heo JD,
Venkatarame Gowda Saralamma V, Ha SE, Kim EH, Mun SP and Kim GS:
Essential oil from Korean Chamaecyparis obtusa leaf
ameliorates respiratory activity in Sprague Dawley rats and
exhibits protection from NF-κB-induced inflammation in WI38
fibroblast cells. Int J Mol Med. 43:393–403. 2019.PubMed/NCBI
|
|
25
|
Zeidler P, Hubbs A, Battelli L and
Castranova V: Role of inducible nitric oxide synthase-derived
nitric oxide in silica-induced pulmonary inflammation and fibrosis.
J Toxicol Environ Health A. 67:1001–1026. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Duru N, Wolfson B and Zhou Q: Mechanisms
of the alternative activation of macrophages and non-coding RNAs in
the development of radiation-induced lung fibrosis. World J Biol
Chem. 7:231–239. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu L, Carron B, Yee HT, Yie TA, Hajjou M
and Rom W: Wnt pathway in pulmonary fibrosis in the bleomycin mouse
model. J Environ Pathol Toxicol Oncol. 28:99–108. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X and Khalil RA: Matrix
metalloproteinases, vascular remodeling, and vascular disease. Adv
Pharmacol. 81:241–330. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gharib SA, Johnston LK, Huizar I, Birkland
TP, Hanson J, Wang Y, Parks WC and Manicone AM: MMP28 promotes
macrophage polarization toward M2 cells and augments pulmonary
fibrosis. J Leukoc Biol. 95:9–18. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mohammed FF, Smookler DS and Khokha R:
Metalloproteinases, inflammation, and rheumatoid arthritis. Ann
Rheum Dis. 62:ii43–ii47. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Q, Park PW, Wilson CL and Parks WC:
Matrilysin shedding of syndecan-1 regulates chemokine mobilization
and transepithelial efflux of neutrophils in acute lung injury.
Cell. 111:635–646. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
McGuire JK, Li Q and Parks WC: Matrilysin
(matrix metalloproteinase-7) mediates E-cadherin ectodomain
shedding in injured lung epithelium. Am J Pathol. 162:1831–1843.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zuo F, Kaminski N, Eugui E, Allard J,
Yakhini Z, Ben-Dor A, Lollini L, Morris D, Kim Y, DeLustro B, et
al: Gene expression analysis reveals matrilysin as a key regulator
of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci USA.
99:6292–6297. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Datta A, Scotton CJ and Chambers RC: Novel
therapeutic approaches for pulmonary fibrosis. Br J Pharmacol.
163:141–172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Craig VJ, Zhang L, Hagood JS and Owen CA:
Matrix metalloproteinases as therapeutic targets for idiopathic
pulmonary fibrosis. Am J Respir Cell Mol Biol. 53:585–600. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee SH, Yeo Y, Kim TH, Lee HL, Lee JH,
Park YB, Park JS, Kim YH, Song JW, Jhun BW, et al Korean
Interstitial Lung Diseases Study Group, : Korean guidelines for
diagnosis and management of interstitial lung diseases: Part 2.
Idiopathic pulmonary fibrosis. Tuberc Respir Dis (Seoul).
82:102–117. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Benjamin MM and Khalil RA: Matrix
metalloproteinase inhibitors as investigative tools in the
pathogenesis and management of vascular disease. Exp Suppl.
103:209–279. 2012.PubMed/NCBI
|
|
38
|
Miao RM, Sun XF, Zhang YY, Wu W, Fang ZH,
Zhao R, Zhao DK, Qian GL and Ji J: Clinical efficacy of tetrandrine
combined with acetylcysteine effervescent tablets in treatment of
silicosis. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi.
31:857–858. 2013.(In Chinese). PubMed/NCBI
|
|
39
|
Xiao Y, Xia H, Zhu L, Li X, Chen R, Yin X,
Jiang Z, Feng L, Chen J, Yu M, et al: Study on the therapeutic
effects of tetrandrine combined with N-acetylcysteine on
experimental silicosis of rats. Zhonghua Lao Dong Wei Sheng Zhi Ye
Bing Za Zhi. 33:519–522. 2015.(In Chinese). PubMed/NCBI
|
|
40
|
Ning JX, Zhang LP and Cui Y: Evaluation of
clinical efficacy of tretrandrine combined with acetylcysteine
effervescent tablets in the treatment of silicosis. Zhonghua Lao
Dong Wei Sheng Zhi Ye Bing Za Zhi. 35:298–299. 2017.(In Chinese).
PubMed/NCBI
|
|
41
|
Miao RM, Zhang XT, Yan YL, He EQ, Guo P,
Zhang YY, Zhao DK, Yang ZG, Chen J, Yao MY, et al: Change of serum
TGF-beta1 and TNF-alpha in silicosis patients. Zhonghua Lao Dong
Wei Sheng Zhi Ye Bing Za Zhi. 29:606–607. 2011.(In Chinese).
PubMed/NCBI
|
|
42
|
Sadikot RT, Blackwell TS, Christman JW and
Prince AS: Pathogen-host interactions in Pseudomonas
aeruginosa pneumonia. Am J Respir Crit Care Med. 171:1209–1223.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hill MR, Briggs L, Montaño MM, Estrada A,
Laurent GJ, Selman M and Pardo A: Promoter variants in tissue
inhibitor of metalloproteinase-3 (TIMP-3) protect against
susceptibility in pigeon breeders' disease. Thorax. 59:586–590.
2004. View Article : Google Scholar : PubMed/NCBI
|
